Watch CBS News

Moderna Submits COVID Booster To FDA

CAMBRIDGE (CBS) - Cambridge-based Moderna has submitted COVID-19 booster shot to the FDA, it announced Wednesday.

The company said a third dose, given in the same concentration as the first two doses can boost a person's immune response to the Delta variant by more than 40 times.

In trials, Moderna gave a third dose to participants 6 months after their second dose of the vaccine. The company said the third dose "induced robust antibody responses" and was as safe as the second dose.

View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.